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http://dx.doi.org/10.1016/j.str.2015.12.002Pathogenic bacteria secrete proteases to evade host defense and to acquire nutrients. In this issue of Struc-
ture, Arolas et al. (2016) describe the structural basis of activation and latency of InhA, a major secreted pro-
tease of Bacillus anthracis.Pathogenic bacteria secrete an arsenal of
highly efficient virulence factors to estab-
lish and maintain infection. With these
virulence factors, the invaders canmanip-
ulate the host’s response to the infection
or even destroy host tissues. An important
subset of these virulence factors is consti-
tuted by proteases. Next to their role in the
defense of the pathogen, proteases play a
role in nutrient acquisition by degradation
of host proteins. Many of the world’s
deadliest toxins are proteases of the met-
alloprotease family, as evidenced by the
tetanus toxin (tetanospasmin) from Clos-
tridium tetani and its cousin, botulinum
toxin from Clostridium botulinum.
One of the most dangerous human
pathogens is Bacillus anthracis, which is
the causative agent of anthrax. The tripar-
tite anthrax toxin is composed of edema
factor (adenylate cyclase), protective anti-
gen (channel-forming protein), and the
metalloprotease lethal factor, which acts
intracellularly on MAPK kinases. Lethal
factor, however, is not the only metallo-
protease contributing to virulence that is
secreted by B. anthracis. Immune inhibi-
tor A (InhA) is another proteolytic enzyme
in the secretome, in which it excerpts its
activity in the extracellular space. InhA
is implicated in several disease-associ-
ated complications (Figure 1A), probably
owing to its low substrate specificity.
All three forms of anthrax—cutaneous,
inhalational and gastrointestinal—are
fatal if left untreated. Fatality is preceded
by a systemic spread of bacteria through
lymphatic or hematogenous routes to
reach many organs. In the brain, the bac-
teria cause hemorrhagic anthrax meningi-
tis facilitated by the action of InhA, which
cleaves zonula occluden-1 protein and in
that way disrupts the blood-brain-barrier
(Mukherjee et al., 2011). Changes in the
coagulation machinery were found to
be associated with anthrax infection.
InhA was found to directly cleave von
Willebrand factor and its regulator,
ADAMTS13, both proteins involved in he-
mostasis and thrombosis (Chung et al.,
2008). InfectionwithB. anthracis activates
the host’s inflammatory response and
leads to sepsis. InhA plays here a
role by indirectly activating acute-phase
response proteins in the liver (Chung
et al., 2009). Next to the effects of InhA
on host proteins leading to a progression
of the disease, the protease plays a role
in processes associated with the physi-
ology of B. anthracis itself (Figure 1B).
InhA was shown to modulate the secre-
tome of B. anthracis, particularly targeting
other secreted proteases and the three
anthrax toxin proteins (Pflughoeft et al.,
2014). Bacteria use adhesins to attach to
the host endothelium during infection.
B. anthracisBslA is a surface-layer protein
that mediates adhesion of vegetative cells
to human endothelial cells. Through
cleavage of BslA, InhA modulates adhe-
sion and mediates dissemination of the
pathogen (Tonry et al., 2012). Moreover,
owing to its low substrate specificity,
InhA may also contribute to the acquisi-
tion of nutrients by the degradation of
host extracellular matrix (ECM) proteins.
Secreted proteases are often synthe-
sized as inactive precursors (proenzymes,
zymogens) to protect the cell from uncon-
trolled proteolysis. Their activation can
be accomplished by themselves (autoac-
tivation) or by other proteases. Many
members of the metzincin family of metal-
loproteases, e.g., reprolysins, matrix met-
alloproteases, and thuringilysins (InhA
belongs to the latter), are synthesized as
proenzymes in which the N-terminal pro-
domains are responsible for sustaining
latency of the protease. The mechanism
of activation is unique for every single
protease and has to be investigated bio-
chemically. In a technically highly sophis-
ticated study, Arolas and colleagues
(2016) investigate the activation and ar-
chitecture of the twoB. anthracis paralogs
InhA1/2 in detail. To obtain substantial
amounts of recombinant protein for
biochemical and structural studies, the
authors first try E. coli as expression
system, the working horse for bacterial
protein production, but they fail. E. coli
produces only insoluble protein, regard-
less of elaborate construct design. The
choice of B. subtilis as expression host
brings the breakthrough and helps pro-
vide reasonable amounts of recombinant
protein that seems to behave in a similar
way as protein expressed in B. anthracis
strain BH460.
InhA1/2 are secreted by B. anthacis as
proenzymes of 84/85 kDa, respectively
(Arolas et al., 2016), that are autolytically
further processed to the mature enzymes
of 73 kDa. The recombinant proteins from
B. subtilis show the stages of autolytic
activation from the proenzyme (84/
85 kDa) over a stable zymogen (82 kDa)
lacking N-terminal residues, which was
crystallized in this study, to the single-
chain active enzyme of 73 kDa (equivalent
to natural InhA1/2) and finally a non-cova-
lently associated two-fragment form of
46+18/55+18 kDa, respectively. In the
latter form, cleavage occurs at position
630/634, which is in a region between
the MAM and VEG domain of InhA1/2.
Removal of the 18 kDa fragment would re-
move most of the VEG domain, that
shares a 3277 A˚2 contact surface with
the 55 kDa fragment (in InhA2), including
5 salt bridges and over 50 hydrogen
bonds (PDB: 4YU6, chain A). The mode
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Figure 1. Biological Functions of B. anthracis InhA Protease
(A) InhA influences many pathways in the human body by either cleaving proteins directly, like vWF,
ADAMTS13, and ZO-1, or by influencing their induction.
(B) InhA modulates about half of the secretome of B. anthracis, degrades extracellular matrix (ECM)
proteins and plasma proteins, and cleaves B. anthracis S-layer protein BslA, consequently mediating
motility of the pathogen.
Structure
Previewsof binding/inhibition of the pro-peptide is
also remarkable. Whereas most pro-pep-
tides bind both parts of the substrate-
binding site (unprimed and primed) and
in a parallel manner to the substrate-
spanning strand (edge strand), which is
opposite to the direction of the substrate
polypeptide chain, the pro-domain of
IhnA2 directly coordinates the zinc ion
from the primed site by its a-amino group,
reminiscent of MMP or serralysin inhibi-
tors (Baumann et al., 1995; Gomis-Ru¨th
et al., 1997). Additionally, the pro-domain
wraps around the InhA2 catalytic domain,
as it would have it literally in a headlock.
There are interesting aspects of the
activation mechanism and the function-
ality of InhA1/2 that have to be answered
in the future. Why did InhA1/2 and related
thuringilysins acquire MAM-domains that
are ofmammalian origin? InhA1/2 variants
lacking the MAM-domain are not only2 Structure 24, January 5, 2016 ª2016 Elsevier Ltd All rights reservedproteolytically inactive, but they also
‘‘loose’’ the VEG-domain. What is the
function of the latter? How does the latent
form become activated, especially as the
cleavage site (residue 139 in InhA2) in
the latent form is located at the lower
back of the catalytic domain, some 45 A˚
away from the catalytic zinc ion? How
can such a ‘‘simple’’ broad-specificity
protease like InhA cleave collagen?
Bona fide (true) collagenases usually are
highly specialized to unwind and cleave
triple-helical structures. Does it cleave
the non-triple-helical regions of collagen?
What are the structural differences be-
tween the two paralogs of InhA? Do they
explain the found differences in proces-
sivity and specificity? We are curious to
hear further news on this important and
fascinating class of proteolytic enzymes.
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